Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
331. |
ECCT/18/10/03 | UMBIFLOW Prevalence and outcomes of abnormal continuous wave Doppler flow indices in unselected obstetric populations in low- and middle-income countries: The Umbiflow International Study. |
Principal Investigator(s) 1. Prof Zahida Parveen Qureshi Site(s) in Kenya 1. Mbagathi District Hospital (Nairobi City county) 2. St. Mary\'s Hospital (Nairobi City county) 3. Kenyatta National Hospital (Nairobi City county) |
View |
332. |
ECCT/18/10/02 | Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya |
Principal Investigator(s) 1. Dr. Nelly Rwamba Mugo 2. Dr. Maricianah Atieno Onono 3. Prof Bukusi Anne Bukusi 4. Dr. Betty Wanjiru Njoroge 5. Dr. Ruanne Barnabas Site(s) in Kenya 1. KEMRI NAIROBI (Nairobi City county) 2. KEMRI KISUMU (Kisumu county) 3. KEMRI THIKA PHRD (Kiambu county) |
View |
333. |
ECCT/18/08/03 | PCVFRACTIONAL DOSE The effect of fractional doses of pneumococcal conjugate vaccines (PCV10 and PCV13) on immunogenicity and vaccine-serotype carriage in Kenyan infants |
Principal Investigator(s) 1. Anthony John Scott Site(s) in Kenya KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya. |
View |
334. |
ECCT/18/08/01 | NOVICE-M Trial NOn-invasive Ventilation In Children with CErebral Malaria Trial |
Principal Investigator(s) 1. Professor Kathryn Maitland Site(s) in Kenya Kilifi County Hospital |
View |
335. |
ECCT/18/07/07 | A Randomized, Open, Parallel-group, Single Dose, Phase 2a Study, to Investigate the Clinical and Parasiticidal Activity and the Pharmacokinetics of 3 dose levels of Artefenomel in combination with Ferroquine (FQ) and FQ alone, in African Patients with Unc A Randomized, Open label, Parallel-group, Single Dose Regimen, Phase 2a Study, to Investigate the Clinical and Parasiticidal Activity and the Pharmacokinetics of 3 dose levels of Artefenomel (OZ439) given in combination with Ferroquine (FQ) and FQ alone, in African Patients with Uncomplicated Plasmodium falciparum Malaria |
Principal Investigator(s) 1. GRACE KIRINGA KAGUTHI Site(s) in Kenya 1. Center for Respiratory Diseases Research (Siaya county) 2. KEMRI (Kisumu county) |
View |